Marimed INC Form 4 insider transactions

Marimed Inc. Director Eva M.D. Selhub converted 166,985 Restricted Stock Units into common stock, increasing her direct beneficial ownership to 482,671 shares.

Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted Restricted Stock Units into common stock and subsequently sold a portion to cover tax obligations.

Marimed Inc.'s President and CEO, Jon R. Levine, reported the conversion of Restricted Stock Units into common stock and a subsequent sale to cover tax obligations.

Marimed Inc. Director Edward J. Gildea converted 247,385 Restricted Stock Units into common stock, increasing his direct beneficial ownership.

Marimed Inc.'s Chief Commercial Officer, Ryan Crandall, received a significant RSU grant and vested existing units, reflecting his recent promotion.

Marimed Inc. Director David R. Allen converted 176,389 Restricted Stock Units into common stock, increasing his direct beneficial ownership.

Marimed Inc. Chief Operating Officer Timothy Shaw reported recent transactions, including a direct purchase of common stock and the conversion of restricted stock units.

Marimed's Chief Commercial Officer, Ryan Crandall, converted 54,000 Restricted Stock Units into common stock, with a portion withheld for tax obligations.

Marimed Inc. Director Edward J Gildea was granted 247,385 Restricted Stock Units as compensation for his board service, vesting on December 15, 2025.

Marimed Inc. Director David R. Allen was granted 176,389 Restricted Stock Units as compensation for his board service, vesting on December 15, 2025.

Marimed Inc. director Eva Selhub M.D. was granted 166,985 Restricted Stock Units as compensation for her board service, vesting fully on December 15, 2025.

Marimed Inc.'s President and CEO, Jon R. Levine, reported the conversion of Restricted Stock Units into common stock and a subsequent tax-related disposition, adjusting his direct and indirect beneficial ownership.

Marimed Inc.'s Chief Commercial Officer, Ryan Crandall, converted 75,000 Restricted Stock Units into common stock and sold shares to cover tax obligations.

Marimed's Chief Operating Officer, Timothy Shaw, reported the conversion of 81,250 Restricted Stock Units into common stock, with a portion withheld for tax obligations.

Marimed Inc.'s President and CEO, Jon R. Levine, reported the conversion of 75,000 Restricted Stock Units into common stock and the subsequent sale of 22,013 shares to cover tax obligations.

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, converted 111,112 Restricted Stock Units into common stock and subsequently disposed of 32,612 shares for tax obligations.

Marimed Inc.'s President and CEO, Jon R. Levine, converted 138,888 Restricted Stock Units into common stock and simultaneously disposed of 40,764 shares to cover tax obligations.

Marimed Inc. COO Timothy Shaw reported the conversion of Restricted Stock Units into common stock and subsequent tax-related share disposition, impacting his direct beneficial ownership.

Marimed Inc. CEO Jon R. Levine disclosed routine transactions involving the vesting of restricted stock units and subsequent share disposals for tax purposes.

Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted 53,572 Restricted Stock Units into common stock and subsequently had 15,347 shares withheld for tax obligations.

Marimed Inc.'s Chief Commercial Officer, Ryan Crandall, converted restricted stock units into common stock and sold a portion for tax obligations.

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, converted Restricted Stock Units into common stock and subsequently sold a portion to cover tax obligations.

Marimed Inc.'s President and CEO, Jon R. Levine, converted Restricted Stock Units into common stock and sold shares to cover tax obligations.

Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted 16,076 Restricted Stock Units into common stock and subsequently sold 4,574 shares to cover tax obligations.

Marimed Inc.'s Chief Commercial Officer, Ryan Crandall, reported the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations.

Marimed's Chief Commercial Officer, Ryan Crandall, reported a planned conversion of 12,500 Restricted Stock Units into common stock and a subsequent tax-related share disposition.

Marimed's Chief Operating Officer, Timothy Shaw, reported the conversion of Restricted Stock Units into common stock and a subsequent tax-related share disposition.

Marimed Inc.'s President and CEO, Jon R. Levine, converted Restricted Stock Units into common stock and sold shares to cover tax obligations.

Marimed Inc. Chief Operating Officer Timothy Shaw converted 65,000 Restricted Stock Units into common stock and had 19,078 shares withheld for tax obligations.

Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted 100,020 Restricted Stock Units into common stock and had 34,657 shares withheld for tax obligations on July 15, 2025.